BANK OF MONTREAL /CAN/ - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 35 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q1 2021$3,000
-84.2%
935
-77.3%
0.00%
Q4 2020$19,000
-13.6%
4,120
+211.2%
0.00%
Q3 2020$22,000
-97.6%
1,324
-98.1%
0.00%
Q2 2020$907,000
+151.9%
68,937
-10.2%
0.00%
Q1 2020$360,000
+3900.0%
76,800
+3740.0%
0.00%
Q4 2019$9,000
+12.5%
2,0000.0%0.00%
Q3 2019$8,0000.0%2,0000.0%0.00%
Q2 2019$8,000
-11.1%
2,0000.0%0.00%
Q1 2019$9,000
+28.6%
2,0000.0%0.00%
Q4 2018$7,000
-12.5%
2,0000.0%0.00%
Q3 2018$8,0000.0%2,0000.0%0.00%
Q2 2018$8,000
+33.3%
2,0000.0%0.00%
Q1 2018$6,000
-25.0%
2,0000.0%0.00%
Q4 2017$8,000
+166.7%
2,000
+100.0%
0.00%
Q1 2016$3,0000.0%1,0000.0%0.00%
Q4 2015$3,000
+50.0%
1,0000.0%0.00%
Q3 2015$2,000
-50.0%
1,0000.0%0.00%
Q2 2015$4,0000.0%1,0000.0%0.00%
Q1 2015$4,000
+33.3%
1,000
+50.2%
0.00%
Q4 2014$3,0000.0%6660.0%0.00%
Q3 2014$3,0006660.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q4 2017
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 241,500$1,093,0000.17%
OCCUDO QUANTITATIVE STRATEGIES LP 90,584$410,0000.13%
EPIQ PARTNERS, LLC 10,550$48,0000.03%
Phoenix Holdings Ltd. 173,683$799,0000.02%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 5,500$25,0000.02%
CFO4Life Group, LLC 12,003$54,0000.02%
HighPoint Advisor Group LLC 15,733$115,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 357,761$1,619,0000.01%
Virtu Financial LLC 24,484$111,0000.01%
ETF MANAGERS GROUP, LLC 93,902$435,0000.01%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders